期刊文献+

内源性大麻素系统与肠易激综合征相关性的研究进展 被引量:1

下载PDF
导出
摘要 肠易激综合征(IBS)是一种常见的胃肠道功能紊乱性疾病,其特征为持续或间歇发作的腹痛、腹胀、排便习惯改变和大便性状异常而无特异的生物化学或形态学异常。最近流行病学调查显示,IBS在西方国家发病率为10%~15%^[1]、在亚洲国家的发病率也达到5%~10%^[2]。在我国,北京地区、广州地区IBS患者占消化门诊患者的比例分别为25%~50%^[3]和34.3%^[41]。IBS具有反复发作的特点,严重降低患者的生活质量,并且占用大量医疗咨派^[5-6]
作者 刘骁 马玉侠
出处 《世界中西医结合杂志》 2013年第7期747-749,756,共4页 World Journal of Integrated Traditional and Western Medicine
基金 国家重点基础研究发展计划(973)课题(No.2007CB512703) 国家自然基金面上项目(No.30973789)
  • 相关文献

参考文献36

  • 1Spinelli A.Irritable bowel syndrome [J].Clin Drug Investig,2007,27(1):15-33.
  • 2ChangFY,Lu CL.Irritable bowel syndrome in the 21st century:per-spectives from Asia or Southeast Asia[J].J Gastroenterol Hepatol,2007,22(1):4-12.
  • 3尉秀清,陈旻湖,王锦辉,胡品津.广州市居民肠易激综合征及功能性便秘的流行病学调查[J].中华内科杂志,2001,40(8):517-520. 被引量:168
  • 4Hungin AP,Whorwell PJ,Tack J,et al.The prevalence,patternsandimpact of irritable bowel syndrome:an international survey of 40,000 subjects [J].Aliment Pharmacol Ther,2003,17(5); 643-650.
  • 5Schonrich S,Brockow T,Franke T,et al.Analyzing the content of out-come measures in clinical trials on irritable bowel syndrome using theinternational classification of functioning,disability and health as areference[J].Rehabilitation(Stuttg),2006,45(3):172-180.
  • 6谈晶晶,韩树堂.肠易激综合征病因学研究进展[J].世界中西医结合杂志,2011,6(5):443-444. 被引量:26
  • 7Woelkart K,Salo-Ahen OM,Bauer R.CB receptor ligands fromplants[J].Curr Top Med Chem,2008,8:173-186.
  • 8Lever U,Rice AS.Cannabinoids and pain[J].Handb Exp Pharma-col,2007(177):265-306.
  • 9ThakurGA,Tichkule R,Bajaj S,et al.Latest advances in cannabi-noid receptor agonists [J].Expert Opin Ther Pat,2009,19(12):1647-1673.
  • 10Graham ES,Ashton JC,Glass M.Cannabinoid receptors:a brief his-tory and1*what^ hot”.[J] Front Biosci,2009,14:944-957.

二级参考文献28

  • 1姜敏,汤浩,刘峥艳,张义侠,傅宝玉.肠易激综合征内脏感知异常与临床症状的相关性[J].世界华人消化杂志,2005,13(4):561-564. 被引量:21
  • 2Nimzing G Ladep,Taiwo J Obindo,Moses D Audu,Edith N Okeke,Abraham O Malu.Depression in patients with irritable bowel syndrome in Jos,Nigeria[J].World Journal of Gastroenterology,2006,12(48):7844-7847. 被引量:22
  • 3Quartilho A, Mata HP, Ibrahim MM,et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology, 2003,99 : 955-960.
  • 4Walker JM, Huang SM, Strangman NM, et al. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A, 1999,96 : 12198-12203.
  • 5Ledent C, Valverde O, Cossu G, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 1999,283:401-404.
  • 6Hohmann AG, Suplita RL, Bohon NM, et al. An endocannabinoid mechanism for stress-induced analgesia. Nature, 2005,435 : 1108- 1112.
  • 7Klein TW, Newton C, Larsen K, et al. The cannabinoid system and immune modulation. J Leukoc Bio1,2003,74:486-496.
  • 8Stefano GB, Salzet M, Rialas, CM. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. J. Cardiol,1998,64:S3-S13.
  • 9Hogestatt ED, Zygmunt PM. Cardiovascular pharmacology of anandamide. Prostaglandins Leukot Essent Fatty Acids,2002,66:343-351.
  • 10Hillard CJ. Endocannabinoids and vascular function. J Pharmacol Exp Ther,2000 , 294:27-32.

共引文献216

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部